APA (7th ed.) Citation

Wang, J., Du, J., Liu, Y., Xu, Y., Han, J., & Zhang, X. (2024). Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China. Vaccines (Basel), 12(12), 1376. https://doi.org/10.3390/vaccines12121376

Chicago Style (17th ed.) Citation

Wang, Jing, Jian Du, Yan Liu, Yuyang Xu, Jiayin Han, and Xuechao Zhang. "Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China." Vaccines (Basel) 12, no. 12 (2024): 1376. https://doi.org/10.3390/vaccines12121376.

MLA (9th ed.) Citation

Wang, Jing, et al. "Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China." Vaccines (Basel), vol. 12, no. 12, 2024, p. 1376, https://doi.org/10.3390/vaccines12121376.